Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case
Authors:
Open Access
- 29 November 2023
- journal article
- research article
- Published by Springer Nature in Radiation Oncology
- Vol. 18 (1) , 1-12
Abstract
Purpose: To report the planning benchmark case results of the POTENTIAL trial—a multicenter, randomized, phase 3 trial—to evaluate the value of internal mammary nodal (IMN) irradiation for patients with high-risk breast cancer. Methods: All participating institutions were provided the outlines of one benchmark case, and they generated radiation therapy plans per protocol. The plans were evaluated by a quality assurance team, after which the institutions resubmitted their revised plans. The information on beams arrangement, skin flash, inhomogeneity corrections, and protocol compliance was assessed in the first and final submission. Results: The plans from 26 institutions were analyzed. Some major deviations were found in the first submission. The protocol compliance rates of dose coverage for the planning target volume of chest wall, supraclavicular fossa plus axilla, and IMN region (PTVim) were all significantly improved in the final submission, which were 96.2% vs. 69.2%, 100% vs. 76.9%, and 88.4% vs. 53.8%, respectively. For OARs, the compliance rates of heart Dmean, left anterior descending coronary artery V40Gy, ipsilateral lung V5Gy, and stomach V5Gy were significantly improved. In the first and final submission, the mean values of PTVim V100% were 79.9% vs. 92.7%; the mean values of heart Dmean were 11.5 Gy vs. 9.7 Gy for hypofractionated radiation therapy and 11.5 Gy vs. 11.0 Gy for conventional fractionated radiation therapy, respectively. Conclusion: The major deviations were corrected and protocol compliance was significantly improved after revision, which highlighted the importance of planning benchmark case to guarantee the planning quality for multicenter trials.Keywords
Funding Information
- the Beijing Hope Run Special Fund of Cancer Foundation of China (LC2019L02, LC2019L02, LC2019L02, LC2019L02, LC2019L02)
- the CAMS Innovation Fund for Medical Sciences (2020-I2M-C&T-B-075)
This publication has 55 references indexed in Scilit:
- EORTC Radiation Oncology Group quality assurance platform: Establishment of a digital central review facilityRadiotherapy and Oncology, 2012
- Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704—A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the PancreasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Volumetric Modulated Arc Therapy Improves Dosimetry and Reduces Treatment Time Compared to Conventional Intensity-Modulated Radiotherapy for Locoregional Radiotherapy of Left-Sided Breast Cancer and Internal Mammary NodesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Inverse-planned, dynamic, multi-beam, intensity-modulated radiation therapy (IMRT): A promising technique when target volume is the left breast and internal mammary lymph nodesMedical Dosimetry, 2006
- Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non–small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Quality Assurance in the EORTC Randomized Trial 22922/10925 Investigating the Role of Irradiation of the Internal Mammary and Medial Supraclavicular Lymph Node Chain WorksStrahlentherapie und Onkologie, 2006
- Number and Orientation of Beams in Inversely Planned Intensity-Modulated Radiotherapy of the Female Breast and the Parasternal Lymph NodesAmerican Journal of Clinical Oncology, 2003
- The potential impact of treatment variations on the results of radiotherapy of the internal mammary lymph node chain: a quality-assurance report on the dummy run of EORTC Phase III randomized trial 22922/10925 in Stage I–III breast cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- Should inhomogeneity corrections be applied during treatment planning of tangential breast irradiation?Radiotherapy and Oncology, 1991